“This is a very interesting article reporting that the spleen enhances TNFα production in the liver. . . [and] showing the intermodulation between organs and the complex mechanisms of physiologic ...

In the pivotal MOMENTUM clinical trial, Omjjara achieved reductions of 50% or more in disease-related symptoms and at least 35% reductions in spleen volume in patients, according to the CHMP.